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Abstract
Background: The purpose of this review was to summarize the up-to-date knowledge on cli-
nical presentation and management of neurocardiogenic injury and to deliver the evidence of 
common pathophysiology of this broad spectrum of disorders.
Methods: Medline and EmBase databases were searched to obtain original research articles 
and review papers using the following key words: neurocardiogenic injury, stress cardiomyo-
pathy, tako-tsubo, subarachnoid hemorrhage, ECG abnormalities, catecholamine toxicity, 
neuropulmonary edema.
Results: Various forms of cerebral pathology, most importantly subarachnoid hemorrhage 
(SAH), are accompanied by transient cardiac dysfunction with ST-segment elevation and QT 
interval prolongation and T wave inversion with simultaneous release of cardiac troponin. In 
the past 20 years a great deal of data emerged concerning stress cardiomyopathy (‘tako-tsubo’) 
presenting as a rare transient apical ballooning syndrome following stressful life events with 
symptoms and signs resembling acute myocardial infarction (AMI), yet without significant 
coronary artery stenosis. Both forms of cardiac dysfunction are mediated by catecholamine 
toxicity, triggered by physical and psychological distress, leading to a specific type of neurogenic 
myocardial stunning reflected by histopathological image of contraction band necrosis.
Conclusions: Neurocardiogenic injury should be carefully differentiated from AMI. Car-
diac dysfunction in SAH heralds increased mortality. The criteria for the diagnosis of stress 
cardiomyopathy should be revised to comprise the diversity of its clinical symptomatology 
and to include cardiac dysfunction accompanying cerebral pathology. (Cardiol J 2014; 21, 
3: 220–228)
Key words: neurocardiogenic injury, stress cardiomyopathy, tako-tsubo,  
subarachnoid hemorrhage, ECG abnormalities 
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Introduction
In the setting of an emergency department, 
clear differentiation between acute myocardial 
infarction (AMI) and other acute conditions requi-
ring prompt management is of vital importance. 
Various neurological disorders, most importantly 
subarachnoid hemorrhage (SAH), were reported 
to have an electrographic presentation resem-
bling characteristic features of AMI in the form 
of repolarization abnormalities (e.g. ST-segment 
elevation) [1]. Commonly considered misleading 
and nonspecific, symptoms of SAH can sometimes 
be almost indistinguishable from those of AMI [2], 
which often leads to initial coronary angiography 
revealing no coronary artery disease (CAD). In 
consequence, referral to neurosurgical department 
is delayed. Surprisingly, impairment of cardiac 
function and electrocardiographic (ECG) abnor-
malities have been demonstrated in miscellaneous 
neurological conditions, such as SAH [3–8] and 
other forms of intracerebral hemorrhage [9], acute 
brain injury [10, 11], cerebral ischemia [12], brain 
tumors [13], refractory status epilepticus [14], 
meningitis [15], intracranial hypertension and brain 
death [16]. First reports of the impact of central 
nervous system on circulation date back to the 
very beginning of the 19th century, when Cushing 
[17] described the physiological blood pressure 
reaction to intracranial hypertension. More to the 
point, in 1990 Sato et al. [18] described an acute 
form of cardiomyopathy characterized by transient 
left ventricle (LV) apical dyskinesia (‘tako-tsubo’ 
cardiomyopathy) triggered by severe psychological 
distress, which provided evidence of extensive 
interactions between brain and heart functions, not 
only on structural, but also on a psychological level. 
Although regarded as different clinical entities, 
both cardiomyopathies share common pathological 
image of myocardial contraction-band necrosis 
[19], which was demonstrated in pheochromocy-
toma-associated cardiac dysfunction [20]. Ample 
scientific evidence advocates in favor of one broad 
spectrum of catecholamine-mediated neurovisceral 
damage, represented by SAH-associated cardiac 
dysfunction [3], tako-tsubo cardiomyopathy [21], 
together with neuropulmonary edema [22]. This 
review sought to encapsulate the up-to-date kno-
wledge on the pathophysiology, clinical presenta-
tion and management of catecholamine-mediated 
neurocardiogenic injury. For this purpose, Medline 
and EmBase databases were searched to obtain 
original research articles and review papers using 
the following key words: neurocardiogenic injury, 
stress cardiomyopathy, tako-tsubo, subarachnoid 
hemorrhage, ECG abnormalities, catecholamine 
toxicity, neuropulmonary edema.
Subarachnoid hemorrhage  
and cardiac dysfunction
Although cardiac dysfunction was encountered 
in various types of cerebral pathology, it is pre-
dominantly linked to SAH. This type of cerebral 
incident is caused by the rupture of aneurysm at 
the branching of arteries located mainly on the 
circle of Willis. Its worldwide incidence reaches 
9.1 per 100,000 person-years and is said to increase 
with age [23]; however, more than 50% of events 
occur in individuals younger than 55 years. SAH is 
also slightly more common in women [7]. Initially, 
patients exhibit a sudden acute headache, described 
as the most severe in a lifetime [24], along with 
epileptic seizures and impaired consciousness in 
2/3 of cases [25], which may involve both quali-
tative (e.g. delirium) and quantitative (e.g. coma) 
disturbances of cognition. Unconscious state 
often precludes a careful medical inquiry into the 
initial presentation. In the setting of emergency 
or cardiology department this can be the source of 
diagnostic errors, especially when accompanied by 
ECG, echocardiographic and enzymatic abnorma-
lities typical for AMI [26].
Preliminary data on the association between 
ECG abnormalities and SAH were published in 
the middle of the 20th century [27]. It was then 
suggested that those findings may actually reflect 
the ongoing autonomic dysfunction, secondary to 
cerebral insult. According to more recent studies, 
69% of patients with SAH present with an abnormal 
admission ECG [6]. Unquestionably, a considerable 
portion of these findings is related to underlying 
CAD or other cardiovascular disorders, as risk 
factors for SAH and CAD are common (e.g. hyper-
tension). ECG abnormalities observed in SAH are 
essentially related with the repolarization phase. 
In a cohort of 222 patients admitted to emergency 
department with the preliminary diagnosis of SAH, 
Huang et al. [1] denoted that patients exhibited 
pathological Q or QS wave (8.1%), ST-segment 
elevation (5%) and depression (10.8%), T-wave 
inversion (9%), peaked upright T-wave (2.2%) and 
nonspecific ST- or T-wave changes (16.2%), as well 
as QT prolongation (mean QT 492 ± 58 ms in non-
-survivors). In addition, several studies reported 
increased rate of prominent U-wave present in up 
to 15% of cases [1]. Worth mentioning is the lack 
of reciprocal lead depressions in case of observed 
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ST-segment elevation. In a multivariate analysis 
model, it was shown that QTc and nonspecific 
repolarization abnormalities were independently 
associated with in-hospital mortality [1]. Further-
more, Coghlan et al. [28] outlined that bradycardia 
(< 60 bpm), relative tachycardia (> 80 bpm) and 
non-specific ST-T abnormalities all corresponded 
with increased 3-month mortality in a cohort of 
588 patients undergoing aneurysm surgery. In 
a different study comprising 100 patients, prolon-
ged QTc (> 460 ms) was the most frequent ECG 
abnormality present in about 16% of patients with 
SAH. Since patients with prolonged QTc were more 
likely to develop the elevation of cardiac troponin I 
(cTI), we may assume that extended QTc interval 
reflects neurocardiogenic injury (OR = 5.5). Howe-
ver, neither QTc nor repolarization abnormalities 
were connected with increased mortality [29].
In this clinical setting we may also occasionally 
observe a specific repolarization abnormality desig-
nated as J wave [30], which was first described by 
Osborn in hypothermic subjects and was further 
reported in hypercalcemia, Brugada syndrome, va-
sospastic angina and, most importantly, intracranial 
hypertension [31]. It is defined as 1 mm positive 
notch at the end of QRS complex with duration of 
≥ 10 ms. Cellular basis for J-wave consists in po-
tential difference between the prominent transient 
outward potassium current (Ito) of epicardium and 
notably smaller Ito current in the endocardial layer 
during phase 1 and 2 of ventricle repolarization 
[32]. The significance of this finding is related 
with frequently observed phase 2 reentrant tachy-
arrhythmia, sustained ventricular tachycardia and 
ventricular fibrillation [33] that can be induced by 
additional currents seen in repolarization period. 
The issue of arrhythmias in the acute phase of SAH 
requires a special consideration as it is responsible for 
a considerable extent of mortality. About 41% of pa-
tients without prior history of cardiovascular disorder 
demonstrated serious ventricular arrhythmias (Lown 
class 4 and 5; ventricular premature contractions 
with couplets or salvos, ventricular tachycardia) and 
4.3% showed life-threatening ventricular arrhythmias 
(torsade de pointes, ventricular flutter or fibrillation) 
[34]. This observation mandates constant ECG moni-
toring in the acute phase of SAH, especially because 
prompt resuscitation has a high success rate and 
more than 50% of survivors of in-hospital cardiac 
arrest manage to live independently without major 
neurological deficits [35].
The evidence of myocardial injury in SAH 
is frequently expressed by means of elevation of 
serum cardiac troponin. High prevalence of cTI 
elevation was documented by Tung et al. [7] who 
estimated that even 20% of patients suffering from 
SAH exhibit a cTI release of more than 1 μg/L. In 
a thorough investigation by Naidech et al. [6], it 
was shown that increased cTI is even more fre-
quent, since 18% of patients had an elevation 
of 0.5–2.0 μg/L, 14% — 2.0–10.0 μg/L and 18% 
— more than 10.0 μg/L. Of note, only 32% of 
subjects had no detectable cTI. Merely 2 out of 
172 patients with elevated cTI concentration 
had normal clinical examination, no regional wall 
motion abnormalities (RWMA) and lack of ECG 
abnormalities, which proves the utility of cardiac 
troponin measurement as an indicator of neuro-
cardiogenic injury [6]. Peak cTI predicted the 
occurrence of echocardiographic LV dysfunction, 
onset of pulmonary edema, severe hypotension 
requiring administration of vasopressive agents 
and delayed cerebral vasospasm [6]. Conversely, 
neurological state on admission (low neurological 
grade, loss of consciousness at ictus, global cere-
bral edema) accurately correlated with cTI release 
suggesting a direct link between neurological and 
cardiac derangement [6].
Injury of cardiomyocytes is also denoted by the 
surge of serum B-type natriuretic peptide (BNP) 
concentration, which exceeds the threshold of 
100 ng/L within 3 days after ictus in about 80% of 
patients [36]. The release of natriuretic peptides 
was previously shown to correlate with LV wall 
stress and diastolic dysfunction encountered in 
chronic heart failure, but in the setting of SAH 
BNP did not correlate with LV filling pressure 
[36]. Never theless, prevalence of diastolic dysfun-
ction reached 71% of all SAH subjects (impaired 
relaxation, pseudonormal, restrictive pattern) 
and was associated with older age and history of 
hypertension [37]. As proven by Kopelnik et al. 
[37], diastolic dysfunction predisposed patients to 
pulmonary edema, while systolic dysfunction was 
considerably less frequent in this clinical scenario.
Last but not least, serial echocardiographic 
examinations enabled to reveal a direct impairment 
of regional cardiac contractility in the acute phase 
of SAH. Consistent with the paper of Kopelnik et 
al. [37], 28% of patients had regional wall motion 
score more than 1 on at least 1 study day, sug-
gesting RWMA [4]. In addition, 15% of patients 
were characterized by impaired global systolic 
function (LVEF < 50%). Regardless of the severity 
of RWMA, a partial or complete reversal within 
the first week of observation was seen in 66% of 
patients [4]. This investigation additionally provi-
ded an intrinsic evidence for the chiefly basal and 
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mid-ventricular hypokinesia with a relatively low 
prevalence of RWMA at the apex of LV [4].
All in all, the importance of neurocardiogenic 
injury in SAH is related not with its frequency 
but with significant impact on the prognosis, as 
peak elevation of cTI was associated with severe 
disability or death at discharge (adjusted OR = 1.4 
per quintile of cTI concentration; 95% CI 1.1–1.9, 
p = 0.02) [6].
Histopathology of neurocardiogenic  
injury in subarachnoid hemorrhage
In this article the authors propose a novel 
approach to both cardiac involvement in the co-
urse of SAH and stress cardiomyopathy (‘tako-
-tsubo’), both regarded as cardiac manifestation 
of catecholamine toxicity. Vast majority of data on 
humans endorsed sympathetic origin of the wide 
spectrum of neurocardiogenic injury through-
out the 20th century. Although this explanation 
was initially a true presumption [38], resounding 
evidence emerged in the form of characteristic 
histopathological image of catecholamine-induced 
lesions. In a couple of post-mortem case series 
[19, 39] it was clearly demonstrated that cerebral 
lesions were accompanied by a distinct type of 
myocardial necrosis, specifically contraction-band 
necrosis (coagulative myocytolysis; myofibrillar 
degeneration), which was first described by Selye 
[40]. The concurrent exposure to steroids (most 
importantly 2-alpha-methyl-9-alpha-fluorocortisol), 
certain electrolytes (NaH2PO4), various hormones 
(vasopressin, adrenaline, insulin, L-thyroxine), and 
a potent stressor (restraint of an animal on a board 
for 15 h or with cold stress) created a predisposi-
tion for the development of scattered myocardial 
necrosis in a hyper-contracted cellular state follow-
ing intracellular Ca++ influx, along with irregular 
intracellular cross-bands, intense cytoplasmic 
eosinophilia and sites of petechial hemorrhage, as 
opposed to classic image of coagulative necrosis 
seen in MI. These lesions were documented to 
have a multifocal subendocardial predilection and 
were prone to early calcification [40].
These myocardial lesions were reproduced 
in an animal model of SAH [39, 40] and their on-
set was successfully prevented by pretreatment 
with neurogenic catecholamine inhibitors, such 
as reserpine (intramyocardial nerve terminals) 
or mecamylamine (ganglionic), which further su-
pported the role of sympathetic nervous system. 
Of note, prevention of adrenomedullary secretion 
of epinephrine by adrenalectomy failed to exert 
sufficient inhibitory influence on formation of 
contraction-band necrosis, which may imply that 
direct sympathetic innervation plays a crucial 
role in pathogenesis of neurocardiogenic injury, 
as opposed to the circulating catecholamine pool.
Autonomic storm
In order to delineate the nature of neurocardio-
genic injury it is indispensable to refer once again 
to Cushing reflex [17]. Seemingly, it plays a role 
in physiology maintaining adequate cerebral blood 
flow during rapid increase of intracranial pressure. 
The adaptation to intracranial hypertension is con-
stricted to mechanical translocation and absorption 
of cerebrospinal fluid, which is of limited capacity to 
control intracranial pressure. According to Monro 
and Kellie [41], hypothesis deriving from incom-
pressibility of cranium, the contents of cranium 
remain in the volatile balance, in which the increase 
in volume of one component results in a decrease of 
another. Provided that the volume of cerebrospinal 
fluid is almost constant, any lesion within cranium 
results in reduction of cerebral blood flow, creating 
a risk of cerebral ischemia. Cushing triad (hyper-
tension, bradycardia and dyspnea/apnea) denotes 
a gradual and stepped autonomic response of va-
somotor center to the above-mentioned situation. 
Initially the sympathetic center is activated, which 
results in the increase of norepinephrine release 
at nerve terminals, activating alpha-1 adrenergic 
receptors, and causing rise in mean arterial pres-
sure (MAP), which constitutes a compensation for 
drop in cerebral perfusion pressure. Moreover, the 
same sympathetic stimulation occurs in pacemaker 
cells and myocardium, causing a rise in heart rate 
and cardiac output. At this point, a parasympathetic 
nervous system is activated through the stimu-
lation of carotid baroreceptors by high MAP or 
through direct distortion of the intracranial portion 
of vagal nerve. Resultant bradycardia stems from 
the prevalence of parasympathetic innervation 
of cardiac conducting system. The final conse-
quence of brainstem compression is dysfunction 
of involuntary breathing, finally leading to apnea. 
This theoretically physiological phenomenon may 
occasionally become maladaptive, especially in 
cases of severe intracranial hypertension, leading 
to over-activity of sympathetic nervous system, 
manifested by increased norepinephrine secretion 
at nerve terminals in myocardium, as well as incre-
ased adrenomedullary production of epinephrine.
An additional mechanism explaining the sur-
ge in serum catecholamine level ensues in case 
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of SAH or stroke. Cerebral representation of 
cardiac function is characterized by a hierarchy 
from brainstem’s reticular network to cortex, 
where conscious awareness of heart function was 
proven by means of heartbeat-evoked potentials 
[42], predominantly in insular cortex, hypothala-
mus and anterior cingulate cortex [43]. Cardiac 
representation in insular cortex was verified by 
intraoperative experiments of Oppenheimer et al. 
[44], who demonstrated that stimulation of right 
insular cortex in humans triggers sympathetic 
response, whereas the stimulation of the left-side 
leads to bradycardia and depressor response. This 
finding was further confirmed in other studies and 
the structure is frequently designated as ‘cardun-
culus’, in correspondence with sensory cortical 
motor and sensory ‘homunculus’ [45].
A direct insult by blood or ischemia to these 
cardiovascular centers may initiate a potentially 
deleterious response of sympathetic nervous sys-
tem, which was demonstrated by Jacob et al. [46], 
who triggered SAH in dogs and obtained hyper-
tension of rapid onset, extreme sinus tachycardia 
with coexisting arrhythmias, rise in LV pressure, 
and increase of coronary blood flow. Contemporary 
reports substantiated increased sympathetic tone 
and elevation of plasma catecholamine concentra-
tion in the course of SAH in humans [7, 47]. In 
the study by Espiner et al. [48], epinephrine and 
norepinephrine concentrations were increased 
and exhibited a gradual decrease following the 
incident. However, Naredi et al. [49] measured 
epinephrine and norepinephrine levels in non-trau-
matic SAH patients using a very precise isotope 
dilution technique and obtained disparity in terms 
of catecholamine concentration. Although total 
norepinephrine release (mostly from sympathetic 
nerve terminals) was 3-fold greater in comparison 
to control groups (healthy individuals and patients 
with refractory pain), there was no statistically sig-
nificant increase compared with healthy subjects in 
the rate of total epinephrine secretion. According 
to this report, elevation of norepinephrine level 
persisted within the first week after insult and 
normalized on follow-up visit after 6 months [49]. 
It is worth to mention that norepinephrine is ef-
ficiently removed by neuronal and extra-neuronal 
uptake, hence circulating norepinephrine repre-
sents merely a small portion of the total amount of 
this neurotransmitter. Moreover, the clinical utility 
of plasma catecholamine concentration is limited, 
since the plasma half-life of both epinephrine 
and norepinephrine is approximately 3 min [50], 
which implies that catecholamine concentration 
measured on admission to emergency department 
does not reflect the initial level during the onset 
of symptoms. In the largest, by far, study on the 
neurocardiogenic injury in SAH, Tung et al. [7] 
investigated into the possible predictors of cardiac 
dysfunction. It was documented that high plasma 
catecholamine concentration does not predict the 
release of cardiac troponin above the threshold of 
1.0 μg/L, which was utilized as an indicator of neu-
rocardiogenic injury [7]. Conversely, in a multiva - 
riate logistic regression analysis, a Hunt-Hess score 
> 2, female gender, larger body surface area and 
LV mass, lower systolic blood pressure and higher 
heart rate, and phenylephrine dose were indepen-
dently associated with cardiac troponin elevation 
[7]. The relationship between Hunt-Hess score 
and extent of myocardial necrosis was previously 
demonstrated by Parekh et al. [5] and constitutes 
an evidence for direct link between the severity of 
neurological derangement and cardiac dysfunction.
Catecholamine-mediated toxicity
Cardiac dysfunction in SAH represents only 
one aspect of a broad spectrum of catecholamine-
-mediated visceral toxicity. Plasma excess of cate-
cholamines or increased sympathetic tone are held 
responsible for the symptomatology of tako-tsubo 
cardiomyopathy, cardiac dysfunction in pheochro-
mocytoma and a novel entity of neuropulmonary 
edema.
Described in 1990 by Sato [18], tako-tsubo 
represents a transient cardiac dysfunction con-
cerning predominantly postmenopausal women, 
in which a potent stressful life event (47% of all 
patients) or physical and neurological distress (in 
about 43% of cases) leads to retrosternal chest 
pain, ST-segment elevation, cardiac troponin 
release, markedly elevated concentration of nore-
pinephrine [51], and transient RWMA mimicking 
ST-segment elevation AMI, yet resolving within 
days or weeks almost in all patients who survived 
the acute period. Coronary angiography reveals 
no hemodynamically significant stenosis of major 
coronary arteries (Table 1). Unlike SAH-associated 
neurocardiogenic injury, RWMA concern predomi-
nantly LV apex, with a characteristic dyskinesia re-
sembling Japanese fishing pot (tako-tsubo) on ven-
triculography or echocardiography. Despite distinct 
manifestation, stress cardiomyopathy shares the 
same histopathological image of contraction-band 
necrosis, which was proven in specimens from 
endomyocardial biopsy [52]. Tako-tsubo has been 
recently demonstrated to be a heterogeneous 
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syndrome with occasional regional wall motion 
abnormalities concerning mid-ventricular (‘apical 
sparing variant’) [53] and basal segments (‘inverted 
variant’) [54].
A possible clue to a different contractile pat-
tern observed in tako-tsubo and cerebral patho-
logy might be the pheochromocytoma-associated 
cardiomyopathy [20], long known to be related 
with excessive secretion of epinephrine and no-
repinephrine from the chromaffin neuroendocrine 
tissue of the tumor of adrenal medulla. The effect 
of catecholamine on myocardium results in the 
histological image of contraction-band necrosis 
and symptomatology resembles that seen in both 
SAH-associated cardiomyopathy and tako-tsubo, 
however, RWMA concern either basal [55], or 
apical segments of LV [56]. This variability of 
RWMA may be dependent on the ratio of epinephri-
ne (prevalence of beta2 stimulation, less potent 
beta1 agonist), norepinephrine (beta1 agonist) and 
dopamine secretion. Accordingly, high density of 
sympathetic innervation in the basal myocardial 
segments (local norepinephrine release) [57] and 
high concentration of norepinephrine (but not epi-
nephrine) in SAH-associated cardiac dysfunction 
implies primarily sympathetic neuronal trafficking 
as a cause of myocardial damage in this instance 
[49]. Conversely, tako-tsubo with its apical dyski-
nesia could ensue from adrenomedullary secretion 
of epinephrine triggered by psychological distress. 
A hypothesis by Lyon et al. [58] indicated that 
apical catecholamine-induced myocardial stunning 
in tako-tsubo might, in fact, be a protective me-
chanism related with transient molecular switch 
in beta2-adrenoreceptors, from Gs to Gi coupling, 
in the event of supraphysiological plasma levels 
of epinephrine. This phenomenon does not occur 
in basal segments, since beta1-adrenoreceptor sti-
mulation from neuronal release of norepinephrine 
outweighs the effects of circulating epinephrine.
From a clinical standpoint, it is vital to be 
aware of the possibility of concurrent lung in-
jury in case of acute cerebrovascular incidents. 
Neuropulmonary edema (NPE) is manifested by 
rapid onset of dyspnea, tachypnea, tachycardia, 
basal pulmonary crackles, respiratory failure and 
decreased PaO2/FiO2 ratio in the event of cerebral 
incident, which represents a direct catecholamine-
-mediated insult to lungs [22]. Adrenergic response 
triggers severe pulmonary vasoconstriction, with 
the resultant rise in hydrostatic pressure and an 
increase in permeability of pulmonary capillaries 
[59]. Although cardiac gallop and RWMA exclude 
pure form of NPE, cardiac function is almost always 
impaired to certain extent, thus it is immensely 
difficult to differentiate between the NPE and pul-
monary edema secondary to reduced cardiac output 
and increased LV end-diastolic pressure associated 
Table 1. Differentiation between neurocardiogenic injury in subarachnoid hemorrhage (SAH) and tako-
-tsubo cardiomyopathy.
Clinical feature Neurocardiogenic injury in SAH Tako-tsubo cardiomyopathy
Precipitating factors Pre-existing clinical condition (SAH,  
intracranial hemorrhage, stroke)
Psychological stress, less frequently  
physical cause (e.g. SAH)
Mechanism Catecholamine toxicity —  
mainly ≠ sympathetic tone
Catecholamine toxicity — mainly ≠ ad - 
renomedullary epinephrine secretion
Symptoms Neurological symptoms: acute,  
severe headache, loss of  
consciousness
Angina-like retrosternal chest pain
Dyspnea
Syncope





•	 (without reciprocal ST depression!)




Basal, mid-ventricular RWMA Apical, mid-ventricular, occasionally  
‘inverted tako-tsubo’ RWMA 
Dynamic LVOT obstruction
Cardiac troponin level Moderate elevation Moderate elevation
Histopathological  
findings
Contraction band necrosis Contraction band necrosis
Prognosis Dependent on the preexisting neurological 
condition; cardiac dysfunction is worse and 
more probable in higher Hunt-Hess grades
Benign, transient cardiac dysfunction, 
mortality is 1–2%
RWMA — regional wall motion abnormalities; LVOT — left ventricular outflow tract
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with acute heart failure. Release of cTI after SAH 
was verified as a predictor of acute lung injury and 
acute respiratory distress syndrome, regardless of 
neurological grade (logOR = 10.2, 95% CI 3.2–31.9, 
p < 0.001) [60]. Both disorders may then coexist, 
contributing to increased mortality and reflecting 
diffuse neurovisceral damage.
Clinical implications and management
Due to extremely low prevalence and lack of 
randomized trials, treatment of neurocardioge-
nic injury remains entirely empirical. In case of 
SAH-related cardiac dysfunction, it is indispensable 
to treat the underlying neurological condition. It 
is commonly believed that the “triple H thera-
py” (hypertension, hypervolemia, hemodilution) 
should not be withdrawn because of the threat of 
pulmonary edema secondary to impaired cardiac 
function. Neither should the aneurysmal surgery 
be postponed due to transient cardiac impairment. 
In the acute phase constant ECG monitoring is 
of utmost importance to early diagnose and treat 
ventricular arrhythmias.
However, when NPE ensues, non-invasive 
ventilation should be used in selected (mild cases) 
or patients should be intubated, sedated and appro-
priately ventilated with positive end-expiratory 
pressure (< 15 cm H2O) and hemodynamically 
supported. Aneurysmal surgery should not be 
postponed for more than 12–24 h after the onset 
of symptoms. Mannitol or hypertonic saline were 
demonstrated, not only to normalize the elevated 
intracranial pressure, but also to increase the 
clearance of pulmonary interstitial fluid in case of 
NPE [61].
Conclusions
Cardiac injury, secondary to both physical 
and psychological insult, is mediated via common 
catecholamine pathway. In patients presenting 
with simultaneous ST-segment elevation, rise of 
cardiac troponin and neuropsychiatric symptoms, 
the decision threshold for conducting computed 
tomography scan before coronary angiography sho-
uld be low. In case of cerebral incidents, evidence 
of cardiac dysfunction indicates adverse course of 
the underlying neurologic disorder and worsens 
the prognosis.
Catecholamine-induced cardio-toxicity is not 
only associated with structural cerebral pathology, 
but its involvement was also proven essential in 
tako-tsubo syndrome and cardiac dysfunction in 
pheochromocytoma. The phenomenon of NPE 
provides the evidence for a wide span of neurovi-
sceral toxicity. In the light of the above-mentioned 
facts, the authors accentuate the need for a broad 
definition of neurocardiogenic injury, as the current 
Classification of the Cardiomyopathies by Ameri-
can Heart Association (2006) [62] incorporates 
merely tako-tsubo cardiomyopathy, defined in line 
with Mayo Clinic diagnostic criteria [63]. Yet, the 
authors conclude that this definition should be 
revised and extended to include all cases of neu-
rocardiogenic injury, also these presenting without 
overt LV apical ballooning.
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